190 related articles for article (PubMed ID: 36377223)
21. ACLY facilitates colon cancer cell metastasis by CTNNB1.
Wen J; Min X; Shen M; Hua Q; Han Y; Zhao L; Liu L; Huang G; Liu J; Zhao X
J Exp Clin Cancer Res; 2019 Sep; 38(1):401. PubMed ID: 31511060
[TBL] [Abstract][Full Text] [Related]
22. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages.
Wang L; Li S; Luo H; Lu Q; Yu S
J Exp Clin Cancer Res; 2022 Oct; 41(1):303. PubMed ID: 36242053
[TBL] [Abstract][Full Text] [Related]
23. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma.
Li D; Liu Z; Ding X; Qin Z
Biomed Res Int; 2021; 2021():3108933. PubMed ID: 34938806
[TBL] [Abstract][Full Text] [Related]
24. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
25. CCL26 silence represses colon cancer by inhibiting the EMT signaling pathway.
Sun A; Li Y; Jiang X
Tissue Cell; 2022 Dec; 79():101937. PubMed ID: 36156375
[TBL] [Abstract][Full Text] [Related]
26. Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion.
Hu HF; Xu WW; Wang Y; Zheng CC; Zhang WX; Li B; He QY
J Proteome Res; 2018 Jan; 17(1):265-275. PubMed ID: 29072916
[TBL] [Abstract][Full Text] [Related]
27. Cellular Model of Colon Cancer Progression Reveals Signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis.
Rokavec M; Horst D; Hermeking H
Cancer Res; 2017 Apr; 77(8):1854-1867. PubMed ID: 28130225
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
29. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
30. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
Fan Y; Wang K
Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998
[TBL] [Abstract][Full Text] [Related]
31. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
33. A disintegrin and metalloproteinase 8 induced epithelial-mesenchymal transition to promote the invasion of colon cancer cells via TGF-β/Smad2/3 signalling pathway.
Jin Q; Jin X; Liu T; Lu X; Wang G; He N
J Cell Mol Med; 2020 Nov; 24(22):13058-13069. PubMed ID: 32954649
[TBL] [Abstract][Full Text] [Related]
34. Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.
Liu B; Xu T; Xu X; Cui Y; Xing X
Mol Cell Biochem; 2018 Dec; 449(1-2):285-294. PubMed ID: 29761248
[TBL] [Abstract][Full Text] [Related]
35. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
36.
Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
[TBL] [Abstract][Full Text] [Related]
37. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
38. THBS2 promotes cell migration and invasion in colorectal cancer via modulating Wnt/β-catenin signaling pathway.
Qu HL; Hasen GW; Hou YY; Zhang CX
Kaohsiung J Med Sci; 2022 May; 38(5):469-478. PubMed ID: 35315209
[TBL] [Abstract][Full Text] [Related]
39. Biglycan enhances the ability of migration and invasion in endometrial cancer.
Sun H; Wang X; Zhang Y; Che X; Liu Z; Zhang L; Qiu C; Lv Q; Jiang J
Arch Gynecol Obstet; 2016 Feb; 293(2):429-38. PubMed ID: 26275380
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.
Wu ZH; Wang XL; Tang HM; Jiang T; Chen J; Lu S; Qiu GQ; Peng ZH; Yan DW
Oncol Rep; 2014 Jul; 32(1):395-402. PubMed ID: 24840737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
